Sema4 a Aktie
WKN DE: A3CVYK / ISIN: US81663L1017
13.01.2025 18:27:42
|
GeneDx Holdings Estimates Rise In Q4, FY24 Revenues; Stock Down
(RTTNews) - GeneDx Holdings Corp. (WGS), Monday reported preliminary results, representing a year-over-year increase of 59 percent and 54 percent for the fourth quarter and full year 2024, respectively.
Revenue for the quarter is expected to be atleast $92 million, whereas the same is predicted to be atleast $299 million for the full year 2024.
Analysts, on average, predict revenue of $80.22 million for the fourth quarter, and $288.2 million for the full year 2024.
Currently, GeneDx's stock is moving down 4.13 percent, to $85.69 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sema4 Holdings Corp Registered Shs -A-mehr Nachrichten
Keine Nachrichten verfügbar. |